AstraZeneca PLC (AZN)
171.49
-1.08
(-0.63%)
USD |
NYSE |
Oct 23, 16:00
171.49
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Market Cap : 531.90B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 531.90B |
| October 22, 2026 | 535.25B |
| October 21, 2026 | 522.48B |
| October 20, 2026 | 523.62B |
| October 19, 2026 | 508.52B |
| October 16, 2026 | 513.05B |
| October 15, 2026 | 516.99B |
| October 14, 2026 | 502.56B |
| October 13, 2026 | 483.30B |
| October 12, 2026 | 491.09B |
| October 09, 2026 | 493.79B |
| October 08, 2026 | 492.48B |
| October 07, 2026 | 496.64B |
| October 06, 2026 | 491.96B |
| October 05, 2026 | 485.50B |
| October 02, 2026 | 486.65B |
| October 01, 2026 | 489.13B |
| September 30, 2026 | 500.83B |
| September 29, 2026 | 509.32B |
| September 28, 2026 | 515.34B |
| September 25, 2026 | 516.68B |
| September 24, 2026 | 510.41B |
| September 23, 2026 | 506.60B |
| September 22, 2026 | 522.23B |
| September 21, 2026 | 521.39B |
| Date | Value |
|---|---|
| September 18, 2026 | 515.12B |
| September 17, 2026 | 515.31B |
| September 16, 2026 | 505.23B |
| September 15, 2026 | 502.00B |
| September 14, 2026 | 507.99B |
| September 11, 2026 | 496.79B |
| September 10, 2026 | 495.15B |
| September 09, 2026 | 486.78B |
| September 08, 2026 | 496.39B |
| September 04, 2026 | 504.64B |
| September 03, 2026 | 511.06B |
| September 02, 2026 | 501.32B |
| September 01, 2026 | 503.93B |
| August 31, 2026 | 502.87B |
| August 28, 2026 | 504.64B |
| August 27, 2026 | 510.29B |
| August 26, 2026 | 515.71B |
| August 25, 2026 | 526.23B |
| August 24, 2026 | 517.08B |
| August 21, 2026 | 514.81B |
| August 20, 2026 | 510.19B |
| August 19, 2026 | 511.62B |
| August 18, 2026 | 496.58B |
| August 17, 2026 | 486.62B |
| August 14, 2026 | 485.26B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 102.65B |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
| Merck & Co., Inc. | 358.62B |
| Novo Nordisk A/S | 130.66B |
Market Cap Related Metrics
| PS Ratio | 8.853 |
| PEG Ratio | 1.514 |
| Price to Book Value | 11.24 |
| Price to Free Cash Flow | 66.50 |
| Price | 171.49 |
| Earnings Yield | 1.94% |
| PEGY Ratio | 1.435 |
| Operating PE Ratio | 38.11 |
| Normalized PE Ratio | 50.91 |